Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
BRIDGE-2M: Optimizing Bridging Therapy Prior to CAR-T Therapy in Multiple Myeloma: A Modified Double-Blind Delphi Panel of US Physicians.
Journal: Advances in therapy
Published: June 01, 2026
Masked divergence in cancer mortality following COVID-19 disruption.
Journal: Cancer epidemiology
Published: April 24, 2026
Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC.
Journal: Current oncology (Toronto, Ont.)
Published: March 17, 2026
High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis.
Journal: Current oncology (Toronto, Ont.)
Published: March 11, 2026
Maintenance Strategies in High-Risk Myeloma: A Multicenter Comparison of Bortezomib-Lenalidomide Versus Lenalidomide Alone: A USMIRC Multicenter Analysis.
Journal: Current oncology (Toronto, Ont.)
Published: January 30, 2026
Current Treatment of Double Refractory Chronic Lymphocytic Leukemia: A Focus on Novel Drugs.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 24, 2026
Review of advances in CAR-T therapies in malignant hematology.
Journal: Frontiers in oncology
Published: December 16, 2025
Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T Recipients.
Journal: European journal of haematology
Published: October 20, 2025
Delayed fatal neurotoxicity in post CAR-T cell therapy for multiple myeloma, a case report.
Journal: Leukemia research reports
Published: August 20, 2025
Immune Effector Cell-Associated HLH-Like Syndrome (IEC-HS) in CAR-T and TCE-Treated Myeloma and B-Cell Malignancies: Insights from a Pharmacovigilance Study.
Journal: Transplantation and cellular therapy
Published: May 31, 2025
Remission of Chimeric Antigen Receptor T-Cell-Refractory Diffuse Large B-Cell Lymphoma Resolved by Surgery and CD20 Bispecific Therapy.
Journal: Cureus
Published: May 22, 2025
The Impact of Sponsors on Development of Clinical Research in Multiple Myeloma and AL Amyloidosis: An In-Depth Analysis.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 07, 2025
Last Updated: 09/26/2026